Verteporfin

Therapeutic Group

Ocular Vascular Disorder Agents

Indication Dosage

Photodynamic Treatment Of Age-related Macular Degeneration Associated With Predominantly Classic Subfoveal Choroidal Neovascularisation Or With Pathological Myopia: 
By IV Infusion: 

  • Adult: 6 Mg/m2, Dose To Be Given Over 10 Minutes

Content

  • Inj 15mg: Verteporfin 15mg; Powder In Vials

Pregnancy

Consult with Doctor Or Caution Advised

Stability

  • Photosensitizer

Contra Indications

  • Acute Porphyria

Precautions

  • Acute Porphyria

Lactation

  • Consult with Doctor Or Caution Advised

Side Effects

  • Flashing Lights
  • Hypercholesterolaemia
  • Malaise
  • Nausea
  • Photosensitivity
  • Reduced Visual Acuity
  • Visual Disturbances
  • Visual-field Defects
  • Back Pain
  • Hyperaesthesia
  • Hypertension
  • Pyrexia
  • Retinal Detachment
  • Subretinal
  • Retinal Or Vitreous Haemorrhage
  • Chest Pain
  • Macular Oedema
  • Myocardial Infarction
  • Retinal Oedema
  • Vasovagal Reactions.
  • Rare: Retinal Or Choroidal Vessel Non-perfusion

Available Brands